Drug
Niacin/Laropiprant
Niacin/Laropiprant is a pharmaceutical drug with 4 clinical trials. Historical success rate of 66.7%.
Total Trials
4
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
66.7%
Based on 2 completed trials
Completion Rate
67%(2/3)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Terminated
1(25%)
Phase Distribution
Ph phase_3
1
25%
Ph phase_4
3
75%
Phase Distribution
0
Early Stage
0
Mid Stage
4
Late Stage
Phase Distribution4 total trials
Phase 3Large-scale testing
1(25.0%)
Phase 4Post-market surveillance
3(75.0%)
Highest Phase Reached
Phase 4Trial Status & Enrollment
Completion Rate
66.7%
2 of 3 finished
Non-Completion Rate
33.3%
1 ended early
Currently Active
0
trials recruiting
Total Trials
4
all time
Status Distribution
Completed(2)
Terminated(1)
Other(1)
Detailed Status
Completed2
unknown1
Terminated1
Development Timeline
Analytics
Development Status
Total Trials
4
Active
0
Success Rate
66.7%
Most Advanced
Phase 4
Trials by Phase
Phase 31 (25.0%)
Phase 43 (75.0%)
Trials by Status
unknown125%
completed250%
terminated125%
Recent Activity
0 active trials
Showing 4 of 4
terminatedphase_4
ER Niacin/Laropiprant Impact on Cardiovascular Markers and Atheroprogression in HIV-infected Individuals on cART
NCT01683656
completedphase_4
Effect of Niacin in the Lipoprotein (a) Concentration
NCT01321034
completedphase_4
Niacin/Laropiprant and Endothelial Function
NCT01126073
unknownphase_3
The Effect of Niacin Administration on Oxidative Stress in Patients With Hypercholesterolmia, as Measured by the Use of a Novel Biomarker
NCT01071525
Clinical Trials (4)
Showing 4 of 4 trials
NCT01683656Phase 4
ER Niacin/Laropiprant Impact on Cardiovascular Markers and Atheroprogression in HIV-infected Individuals on cART
NCT01321034Phase 4
Effect of Niacin in the Lipoprotein (a) Concentration
NCT01126073Phase 4
Niacin/Laropiprant and Endothelial Function
NCT01071525Phase 3
The Effect of Niacin Administration on Oxidative Stress in Patients With Hypercholesterolmia, as Measured by the Use of a Novel Biomarker
All 4 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 4